HER-2(+)HR(-)新辅助重要临床试验

1. KATHERINE

2. PEONY

3. NeoSphere

bpCR: 45.8% vs 29.0% vs 24.0% vs 16.8%

5年的PFS: 86% vs 81% vs 73% vs 73%

5年的DFS: 84% vs 81% vs 80% vs 75%

4. TRAIN-2

tpCR: 蒽环组67% vs 无蒽环组68%